Ademuyiwa, Foluso O. http://orcid.org/0000-0002-6766-2258
Gao, Feng
Street, Cherease R.
Chen, Ina
Northfelt, Donald W.
Wesolowski, Robert
Arora, Mili
Brufsky, Adam http://orcid.org/0000-0001-8080-7960
Dees, E. Claire
Santa-Maria, Cesar A. http://orcid.org/0000-0003-0979-8787
Connolly, Roisin M. http://orcid.org/0000-0003-0056-1070
Force, Jeremy http://orcid.org/0000-0002-3326-2715
Moreno-Aspitia, Alvaro
Herndon, John M. http://orcid.org/0000-0002-8378-9654
Carmody, Madelyn
Davies, Sherri R. http://orcid.org/0000-0002-7141-8354
Larson, Sarah
Pfaff, Kathleen L.
Jones, Stephanie M.
Weirather, Jason L. http://orcid.org/0000-0003-0556-0616
Giobbie-Hurder, Anita http://orcid.org/0000-0003-2496-7737
Rodig, Scott J.
Liu, Zheng
Hagemann, Ian S. http://orcid.org/0000-0002-3855-9745
Sharon, Elad http://orcid.org/0000-0002-0044-9719
Gillanders, William E. http://orcid.org/0000-0002-0465-3071
Funding for this research was provided by:
Institute of Clinical and Translational Sciences (UL1 TR002345)
Article History
Received: 29 March 2021
Accepted: 13 December 2022
First Online: 30 December 2022
Competing interests
: F.O.A. declares no competing non-financial interests but the following competing financial interests from Astra Zeneca, Gilead, Biotheranostics, Athenex, QED, Cardinal Health, Teladoc Health, Pfizer, and research grants to her institution from Pfizer, Seattle Genetics, Immunomedics, NeoImmuneTech, RNA Diagnostics, Astellas. F.G., C.R.S., I.C. and D.W.N. declare no competing financial or non-financial interests. R.W. declares competing financial interests from Seagen and declares competing non-financial interests as a scientific steering committee member for Celcuity. M.A. declares no competing financial or non-financial interests. A.B. declares no competing non-financial interests but the following competing financial interests from Roche, Pfizer, Astra Zeneca, and Merck. C.D. declares no competing financial or non-financial interests. C.A.S.-M. declares no competing non-financial interests but the following competing financial interests from Seattle Genetics, Genomic Health, Athenex, Polyphor, Halozyme, and research grants to his institution from Astrazeneca, Pfizer, Novartis, Tesaro/GSK. R.M.C. declares no competing non-financial interests but the following competing financial interests as research grants to her institution from Novartis, Puma Biotechnology, Merck, Genentech, and Macrogenics. J.F. declares no competing non-financial interests but the following competing financial interests from Genomic Health, and ownership interests in Genomic Health, and Immunomedics. A.M.-A. declares no competing non-financial interests but the following competing financial interests as research grants to his institution from Genentech, GSK. J.M.H., M.C., S.R.D., S.L., K.L.P., S.M.J., J.L.W., A.G.-H., S.J.R., Z.L., I.H., E.S. and W.E.G. declare no competing financial or non-financial interests.